“…Of the 272 excluded studies, 44 were duplicate publications; 196 were not relevant to VDR gene polymorphisms and CAD risk; 12 were reviews, editorials, or comments; 4 were case reports; 5 were studies that reported on the association between other polymorphisms of the VDR gene and CAD risk; 4 were on patients with diabetes or kidney disorders; 2 were studies without any control group; and 8 were other irrelevant articles. A total of 8 relevant studies (cases, 5,259; controls, 1,981) were finally included based on the inclusion criteria for CAD susceptibility related to the Fok I, Bsm I, Taq I, and Apa I polymorphisms [24,25,26,27,28,29,30,31,32]. Of these, 7 studies were performed in Caucasians [24,25,26,27,29,30,32], and 2 studies [28,31] were performed in East-Asians.…”